Endovia Health Sciences, Inc.
EDVA
22 hedge funds and large institutions have $6.81M invested in Endovia Health Sciences, Inc. in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 10 closing their positions.
171% more call options, than puts
Call options by funds: $2.49M | Put options by funds: $918K
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.01% less ownership
Funds ownership: 0.05% → 0.04% (-0.01%)
8% less funds holding
Funds holding: 24 → 22 (-2)
14% less capital invested
Capital invested by funds: $7.96M → $6.81M (-$1.15M)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$147K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$80.2K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$73K |
| 4 |
TF
TRH Financial
North Liberty,
Iowa
|
+$67.9K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$54.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$772K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$310K |
| 3 |
VF
Virtu Financial
New York
|
-$259K |
| 4 |
Two Sigma Investments
New York
|
-$208K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$199K |
EDVA Hedge Fund Activity: Q2 2022 in Review
22 of the 5,958 institutional investors tracked by Wall St. Rank reported a position in Endovia Health Sciences, Inc. (EDVA) for Q2 2022, worth a combined $6.81M — down 14% from $7.96M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of EDVA and 8 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was BlackRock, opening a new position worth an estimated $147K. The largest seller was EAM Investors, exiting entirely with an estimated $772K sold.
- 22 institutional investors held Endovia Health Sciences, Inc. (EDVA) as of Q2 2022, down from 24 in Q1 2022.
- Funds reported $6.81M of Endovia Health Sciences, Inc. stock for Q2 2022, down 14% quarter-over-quarter.
- 8 funds opened new Endovia Health Sciences, Inc. positions in Q2 2022 and 10 closed out, a net change of -2 holders.
- The largest Endovia Health Sciences, Inc. buyer in Q2 2022 was BlackRock, an estimated $147K added.
- The largest Endovia Health Sciences, Inc. seller in Q2 2022 was EAM Investors, an estimated $772K sold.
Based on aggregated 13F filings for Q2 2022.